BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours.

Br J Cancer · 2008 · PMC2243163 · PMID 18195709

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Indeed, BORIS has been implicated in the initiation of a series of methylation events at the imprinting control regions, in the vicinity of the CTCF-/BORIS-binding sites ( Jelinic et al , 2006 ), which may be significant for cancer development ( Jelinic and Shaw, 2007 ).

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.